A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate
S B Cohen, L W Moreland, J J Cush, M W Greenwald, S Block, W J Shergy, P S Hanrahan, M M Kraishi, A Patel, G Sun, M B Bear
Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1062-1068; DOI: 10.1136/ard.2003.016014